NCT00995618View on ClinicalTrials.gov

Study of Tranilast Alone or in Combination With Febuxostat in Patients With Hyperuricemia

PHASE2CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

September 30, 2009

Primary Completion Date

April 30, 2010

Study Completion Date

April 30, 2010

Conditions
GoutHyperuricemia
Interventions
DRUG

Tranilast

Tranilast tablets, 300 mg, QD

DRUG

Febuxostat

Febuxostat Tablets, 40 mg, QD

DRUG

Combination - Tranilast and Febuxostat

Tranilast, 300 mg QD; Febuxostat, 40 mg QD

Trial Locations (3)

Unknown

Nuon Investigative Site, Honolulu

Nuon Investigative Site, Evansville

Nuon Investigative Site, Dallas

Sponsors
All Listed Sponsors
lead

Nuon Therapeutics, Inc.

INDUSTRY